Acquisition Announced Sponsor buyer
Tamarind Health acquisition of Hong Kong Women’s Imaging, Hong Kong MRI and Hong Kong Medical Imaging group
Announced 27 May 2026
Advisers
Hong Kong Women’s Imaging, Hong Kong MRI and Hong Kong Medical Imaging group
Target
Not disclosed
Tamarind Health
Acquirer
- Legal adviser
- Target
- Hong Kong Women’s Imaging, Hong Kong MRI and Hong Kong Medical Imaging group
- Acquirer
- Tamarind Health
- Sponsor
- Templewater
- Target based in
- Hong Kong
- Buyer based in
- Singapore
- Sector
- Healthcare Services
- Tags
- Healthcare Services, Diagnostics, Oncology
Similar deals
- Labcorp acquisition of Select assets of BioReference Health Oct 2026 · Diagnostics
- Tempus AI acquisition of Personalis Jul 2026 · US$1.9bn · Diagnostics
- Proposed Ignite Proteomics Inc. holding company and Ignite Proteomics merger Jun 2026 · US$150m · Life Sciences
- Roche acquisition of SAGA Diagnostics Jun 2026 · US$595m · Diagnostics
- CareDx acquisition of Naveris Apr 2026 · US$160m · Diagnostics
Sources
- 27 May 2026 Goodwin Advised on the Acquisition of Hong Kong Women’s Imaging Group goodwinlaw.com
